Tirzepatide, as a dual GIP/GLP-1 agonist, may produce slightly more pronounced effects because it typically produces greater weight loss (15% to 20% of body weight versus 10% to 15% for pure GLP-1 agonists) and more dramatic metabolic improvements
TrimRx operates as a telehealth platform that partners with US state-licensed 503A pharmacies
Maintaining Weight Loss After Tirzepatide Maintaining weight loss requires ongoing effort
You may experience minor discomfort or slight stinging, but this subsides quickly
Both produce HbA1C reductions of 1.5-2.5% in diabetic populations, which is clinically significant and superior to most oral antidiabetic agents
If it spreads, becomes painful, or you develop systemic signs, seek medical evaluation without delay